MarketCap
Tenax Therapeutics TENX
€ 1.75
2.59%
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
39.2 M |
Marktkapitalisierung |
$ 76.9 M |
EBITDA (LTM) |
$ -56.4 M |
P/E (LTM) |
-1.447761 |
P/S (LTM) |
- |
EPS (LTM) |
-1.34 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Eli Lilly and Company
LLY
|
$ 1 143.12 | 0.02 % | $ 1.03 T | NYSE,SPB | USA |
 |
Lipocine
LPCN
|
$ 2.07 | 0.98 % | $ 11.3 M | Nasdaq Global Select Market | USA |
 |
Liquidia Corporation
LQDA
|
$ 27.64 | 2.32 % | $ 2.38 B | Nasdaq Capital Market | USA |
 |
Larimar Therapeutics
LRMR
|
$ 2.86 | 1.75 % | $ 238 M | Nasdaq Global Market | USA |
 |
Lantern Pharma
LTRN
|
$ 0.94 | 9.3 % | $ 10.2 M | Nasdaq Global Select Market | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
$ 1.74 | 0.82 % | $ 632 M | Nasdaq Global Select Market | USA |
 |
Mustang Bio
MBIO
|
$ 0.46 | 1.16 % | $ 2.26 M | Nasdaq Global Market | USA |
 |
Moleculin Biotech
MBRX
|
$ 0.48 | 0.42 % | $ 569 K | Nasdaq Global Select Market | USA |
 |
Seres Therapeutics
MCRB
|
$ 2.85 | 0.34 % | $ 25.2 M | Nasdaq Global Select Market | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
$ 493.62 | 0.1 % | $ 11.1 B | Nasdaq Global Select Market,SPB | USA |
 |
MediWound Ltd.
MDWD
|
$ 13.51 | 0.22 % | $ 368 M | Nasdaq Global Select Market |  Israel |
 |
Mesoblast Limited
MESO
|
$ 14.22 | 0.99 % | $ 17.2 B | Nasdaq Global Select Market |  Australia |
 |
MacroGenics
MGNX
|
$ 3.77 | 5.31 % | $ 238 M | Nasdaq Global Select Market | USA |
 |
MeiraGTx Holdings plc
MGTX
|
$ 10.92 | 1.2 % | $ 878 M | Nasdaq Global Select Market | USA |
 |
Mirum Pharmaceuticals
MIRM
|
$ 81.43 | 0.07 % | $ 4.09 B | Nasdaq Global Select Market | USA |
 |
Milestone Pharmaceuticals
MIST
|
$ 0.78 | 0.25 % | $ 82.9 M | Nasdaq Global Select Market |  Canada |
 |
MannKind Corporation
MNKD
|
$ 3.82 | 0.53 % | $ 1.17 B | Nasdaq Global Market | USA |
 |
MediciNova
MNOV
|
$ 1.76 | 0.28 % | $ 86.4 M | Nasdaq Global Market | USA |
|
Monopar Therapeutics
MNPR
|
$ 78.29 | 0.41 % | $ 580 M | Nasdaq Global Select Market | USA |
 |
Mereo BioPharma Group plc
MREO
|
$ 0.39 | 2.16 % | $ 311 M | Nasdaq Global Select Market |  Britain |
 |
Merck & Co.
MRK
|
$ 139.54 | 0.34 % | $ 349 B | NYSE,SPB | USA |
 |
Marker Therapeutics
MRKR
|
$ 1.06 | 0.95 % | $ 16.2 M | Nasdaq Global Market | USA |
 |
Moderna
MRNA
|
$ 203.21 | 6.95 % | $ 79 B | Nasdaq Global Select Market,SPB | USA |
 |
Maravai LifeSciences Holdings
MRVI
|
$ 8.52 | 7.85 % | $ 1.23 B | Nasdaq Global Select Market | USA |
 |
Matinas BioPharma Holdings
MTNB
|
$ 2.82 | 6.82 % | $ 15.4 M | NYSE American | USA |
 |
RAPT Therapeutics
RAPT
|
- | - | $ 2.36 B | Nasdaq Global Select Market | USA |
 |
Neurocrine Biosciences
NBIX
|
$ 144.21 | 0.72 % | $ 14.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Nanobiotix S.A.
NBTX
|
$ 25.1 | 0.16 % | $ 1.2 T | Nasdaq Global Select Market |  France |
 |
NuCana plc
NCNA
|
$ 1.06 | 2.75 % | $ 11.9 B | Nasdaq Global Select Market | Britain |
 |
Minerva Neurosciences
NERV
|
$ 3.32 | 1.22 % | $ 28.1 M | Nasdaq Global Market | USA |
 |
Nektar Therapeutics
NKTR
|
$ 42.22 | 2.2 % | $ 712 M | Nasdaq Global Select Market,SPB | USA |
 |
Nkarta
NKTX
|
$ 2.53 | 0.59 % | $ 187 M | Nasdaq Global Select Market | USA |
 |
NanoViricides
NNVC
|
$ 1.45 | 13.28 % | $ 29.3 M | NYSE American | USA |
 |
Nurix Therapeutics
NRIX
|
$ 22.88 | 0.09 % | $ 1.98 B | Nasdaq Global Select Market,SPB | USA |
|
Nuvation Bio
NUVB
|
$ 4.95 | 1.07 % | $ 1.69 B | NYSE | USA |
 |
Novavax
NVAX
|
$ 12.56 | 20.08 % | $ 2.03 B | Nasdaq Global Select Market | USA |
 |
Novo Nordisk A/S
NVO
|
$ 37.54 | 0.59 % | $ 167 B | NYSE |  Danmark |
 |
Novartis AG
NVS
|
$ 140.93 | 0.01 % | $ 273 B | NYSE |  Schweiz |
 |
NextCure
NXTC
|
$ 5.05 | 0.59 % | $ 14.4 M | Nasdaq Global Select Market | USA |
 |
Ocugen
OCGN
|
$ 1.04 | 1.96 % | $ 325 M | Nasdaq Capital Market | USA |
 |
Ocular Therapeutix
OCUL
|
$ 7.25 | 4.17 % | $ 1.36 B | Nasdaq Global Select Market | USA |
 |
Oragenics
OGEN
|
$ 0.49 | 1.25 % | $ 1.06 M | NYSE American | USA |
 |
Olema Pharmaceuticals
OLMA
|
$ 8.25 | 0.3 % | $ 718 M | Nasdaq Global Select Market | USA |
 |
Omeros Corporation
OMER
|
$ 18.9 | 1.56 % | $ 1.2 B | Nasdaq Global Select Market | USA |
 |
Oncolytics Biotech
ONCY
|
$ 0.6 | 1.21 % | $ 57.5 M | Nasdaq Global Select Market | Canada |
 |
ORIC Pharmaceuticals
ORIC
|
$ 12.49 | 2.34 % | $ 1.1 B | Nasdaq Global Select Market | USA |
 |
Oramed Pharmaceuticals
ORMP
|
$ 4.55 | 1.34 % | $ 188 M | Nasdaq Global Select Market | Israel |
 |
Outlook Therapeutics
OTLK
|
$ 0.6 | 0.42 % | $ 20.9 M | Nasdaq Global Select Market | USA |
 |
Ovid Therapeutics
OVID
|
$ 2.34 | 0.21 % | $ 305 M | Nasdaq Global Select Market | USA |
 |
Passage Bio
PASG
|
$ 4.09 | 0.73 % | $ 13.1 M | Nasdaq Global Select Market | USA |